A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor
Clinical trial NCT01283971 · TERMINATED
Trial details
- NCT number
- NCT01283971
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-08-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.